Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1 inhibitor deficiency: consensus document.

M M Gompels1, R J Lock, M Abinun

  • 1Department of Immunology and Immunogenetics, North Bristol NHS Trust, Southmead Hospital, Bristol, UK. mark.gompels@nbt.nhs.uk

Clinical and Experimental Immunology
|February 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Failure of the femoral stem: A case series of intra-prosthetic fractures and proposed classification system.

Journal of orthopaedics·2026
Same author

Pain after lower limb amputation.

BJA education·2026
Same author

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.

Allergy·2026
Same author

Implementation considerations for integrated face and respiratory protection: a qualitative study.

The Journal of hospital infection·2025
Same author

The risk of revision surgery after trainee-led primary total hip replacement.

Annals of the Royal College of Surgeons of England·2024
Same author

Molecular signatures of cortical expansion in the human foetal brain.

Nature communications·2024
Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026
Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026
Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026
Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026
Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026
Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026
See all related articles

Hereditary angio-oedema, caused by C1 inhibitor deficiency, presents with recurrent swelling. Diagnosis involves low C4 and C1 inhibitor levels, with treatments ranging from concentrates to androgens.

Area of Science:

  • Immunology
  • Genetics

Background:

  • Hereditary angio-oedema (HAE) is a rare autosomal dominant disorder.
  • It results from reduced C1 inhibitor (C1-INH) function due to genetic defects.
  • Clinical manifestations include recurrent angio-oedema, potentially affecting the larynx or gastrointestinal tract.

Framework:

  • Diagnosis is confirmed by low serum C4 and absent/reduced C1 inhibitor levels or function.
  • Attacks can be triggered by trauma, infection, or other stimuli.
  • Management strategies are stratified based on attack severity and swelling location.

Implementation:

  • Acute treatment for severe attacks involves C1 inhibitor concentrate infusion.
  • Minor attacks may be treated with attenuated androgens or tranexamic acid.

Related Experiment Videos

  • Prophylaxis utilizes attenuated androgens and/or tranexamic acid.
  • Implications:

    • New therapies in clinical trials include engineered C1-INH, kallikrein inhibitors, and bradykinin B2 receptor antagonists.
    • Guidelines address diagnosis, management, prophylaxis, emergency care, and special populations (children, pregnant women, travelers).
    • Optimal service specifications are crucial for comprehensive HAE care.